| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $21.0M | -79.1% |
| R&D Expense | $123.1M | -33.8% |
| SG&A Expense | $54.0M | -9.4% |
| Operating Income | -$156.0M | -7.6% |
| Pre-tax Income | -$142.8M | -20.1% |
| Income Tax | $168K | +31.3% |
| Net Income | -$142.9M | -20.1% |
| EPS (Basic) | -$1.39 | -13.0% |
| EPS (Diluted) | -$1.39 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $65.8M | +99.3% |
| Short-term Investments | $190.2M | -50.0% |
| Current Assets | $266.5M | -37.3% |
| Total Assets | $293.2M | -37.4% |
| Current Liabilities | $69.5M | -44.4% |
| Long-term Debt | $10.0M | +0.0% |
| Total Liabilities | $262.6M | -23.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$184.0M | +20.0% |
| Capital Expenditures | $41K | -96.7% |
| Investing Cash Flow | $196.6M | +83.5% |
| Financing Cash Flow | $20.2M | -75.2% |
| Free Cash Flow | -$184.1M | +20.4% |
| -13.0% |
| Stockholders' Equity |
| $30.6M |
| -75.8% |